Literature DB >> 28151746

Matching Weights to Simultaneously Compare Three Treatment Groups: Comparison to Three-way Matching.

Kazuki Yoshida1, Sonia Hernández-Díaz, Daniel H Solomon, John W Jackson, Joshua J Gagne, Robert J Glynn, Jessica M Franklin.   

Abstract

BACKGROUND: Propensity score matching is a commonly used tool. However, its use in settings with more than two treatment groups has been less frequent. We examined the performance of a recently developed propensity score weighting method in the three-treatment group setting.
METHODS: The matching weight method is an extension of inverse probability of treatment weighting (IPTW) that reweights both exposed and unexposed groups to emulate a propensity score matched population. Matching weights can generalize to multiple treatment groups. The performance of matching weights in the three-group setting was compared via simulation to three-way 1:1:1 propensity score matching and IPTW. We also applied these methods to an empirical example that compared the safety of three analgesics.
RESULTS: Matching weights had similar bias, but better mean squared error (MSE) compared with three-way matching in all scenarios. The benefits were more pronounced in scenarios with a rare outcome, unequally sized treatment groups, or poor covariate overlap. IPTW's performance was highly dependent on covariate overlap. In the empirical example, matching weights achieved the best balance for 24 out of 35 covariates. Hazard ratios were numerically similar to matching. However, the confidence intervals were narrower for matching weights.
CONCLUSIONS: Matching weights demonstrated improved performance over three-way matching in terms of MSE, particularly in simulation scenarios where finding matched subjects was difficult. Given its natural extension to settings with even more than three groups, we recommend matching weights for comparing outcomes across multiple treatment groups, particularly in settings with rare outcomes or unequal exposure distributions. See video abstract at, http://links.lww.com/EDE/B188.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28151746      PMCID: PMC5378668          DOI: 10.1097/EDE.0000000000000627

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  19 in total

1.  Marginal structural models as a tool for standardization.

Authors:  Tosiya Sato; Yutaka Matsuyama
Journal:  Epidemiology       Date:  2003-11       Impact factor: 4.822

2.  A modified poisson regression approach to prospective studies with binary data.

Authors:  Guangyong Zou
Journal:  Am J Epidemiol       Date:  2004-04-01       Impact factor: 4.897

3.  The comparative safety of analgesics in older adults with arthritis.

Authors:  Daniel H Solomon; Jeremy A Rassen; Robert J Glynn; Joy Lee; Raisa Levin; Sebastian Schneeweiss
Journal:  Arch Intern Med       Date:  2010-12-13

4.  Diagnosing and responding to violations in the positivity assumption.

Authors:  Maya L Petersen; Kristin E Porter; Susan Gruber; Yue Wang; Mark J van der Laan
Journal:  Stat Methods Med Res       Date:  2010-10-28       Impact factor: 3.021

5.  Estimating causal effects from epidemiological data.

Authors:  Miguel A Hernán; James M Robins
Journal:  J Epidemiol Community Health       Date:  2006-07       Impact factor: 3.710

6.  Metrics for covariate balance in cohort studies of causal effects.

Authors:  Jessica M Franklin; Jeremy A Rassen; Diana Ackermann; Dorothee B Bartels; Sebastian Schneeweiss
Journal:  Stat Med       Date:  2013-12-09       Impact factor: 2.373

7.  Control of confounding in the assessment of medical technology.

Authors:  S Greenland; R Neutra
Journal:  Int J Epidemiol       Date:  1980-12       Impact factor: 7.196

Review 8.  Active-comparator design and new-user design in observational studies.

Authors:  Kazuki Yoshida; Daniel H Solomon; Seoyoung C Kim
Journal:  Nat Rev Rheumatol       Date:  2015-03-24       Impact factor: 20.543

9.  The use of bootstrapping when using propensity-score matching without replacement: a simulation study.

Authors:  Peter C Austin; Dylan S Small
Journal:  Stat Med       Date:  2014-08-04       Impact factor: 2.373

Review 10.  Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies.

Authors:  Peter C Austin; Elizabeth A Stuart
Journal:  Stat Med       Date:  2015-08-03       Impact factor: 2.373

View more
  31 in total

1.  A tool for empirical equipoise assessment in multigroup comparative effectiveness research.

Authors:  Kazuki Yoshida; Daniel H Solomon; Sebastien Haneuse; Seoyoung C Kim; Elisabetta Patorno; Sara K Tedeschi; Houchen Lyu; Sonia Hernández-Díaz; Robert J Glynn
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-05-27       Impact factor: 2.890

2.  Comparison of Teriparatide and Denosumab in Patients Switching From Long-Term Bisphosphonate Use.

Authors:  Houchen Lyu; Sizheng S Zhao; Kazuki Yoshida; Sara K Tedeschi; Chang Xu; Sagar U Nigwekar; Benjamin Z Leder; Daniel H Solomon
Journal:  J Clin Endocrinol Metab       Date:  2019-11-01       Impact factor: 5.958

3.  Multinomial Extension of Propensity Score Trimming Methods: A Simulation Study.

Authors:  Kazuki Yoshida; Daniel H Solomon; Sebastien Haneuse; Seoyoung C Kim; Elisabetta Patorno; Sara K Tedeschi; Houchen Lyu; Jessica M Franklin; Til Stürmer; Sonia Hernández-Díaz; Robert J Glynn
Journal:  Am J Epidemiol       Date:  2019-03-01       Impact factor: 4.897

4.  Methodological considerations when analysing and interpreting real-world data.

Authors:  Til Stürmer; Tiansheng Wang; Yvonne M Golightly; Alex Keil; Jennifer L Lund; Michele Jonsson Funk
Journal:  Rheumatology (Oxford)       Date:  2020-01-01       Impact factor: 7.580

5.  Effects of analgesics on bone mineral density: A longitudinal analysis of the prospective SWAN cohort with three-group matching weights.

Authors:  Kazuki Yoshida; Zhi Yu; Gail A Greendale; Kristine Ruppert; Yinjuan Lian; Sara K Tedeschi; Tzu-Chieh Lin; Sebastien Haneuse; Robert J Glynn; Sonia Hernández-Díaz; Daniel H Solomon
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-12-12       Impact factor: 2.890

6.  No difference between direct-acting antivirals for hepatitis C in hepatocellular carcinoma risk.

Authors:  Elijah J Mun; Pamela Green; Kristin Berry; George N Ioannou
Journal:  Eur J Gastroenterol Hepatol       Date:  2019-01       Impact factor: 2.566

7.  Validity of Privacy-Protecting Analytical Methods That Use Only Aggregate-Level Information to Conduct Multivariable-Adjusted Analysis in Distributed Data Networks.

Authors:  Xiaojuan Li; Bruce H Fireman; Jeffrey R Curtis; David E Arterburn; David P Fisher; Érick Moyneur; Mia Gallagher; Marsha A Raebel; W Benjamin Nowell; Lindsay Lagreid; Sengwee Toh
Journal:  Am J Epidemiol       Date:  2019-04-01       Impact factor: 4.897

8.  Heart Failure Hospitalization Risk associated with Iron Status in Veterans with CKD.

Authors:  Monique E Cho; Jared L Hansen; Brian C Sauer; Alfred K Cheung; Adhish Agarwal; Tom Greene
Journal:  Clin J Am Soc Nephrol       Date:  2021-03-29       Impact factor: 8.237

9.  Propensity Scores in Pharmacoepidemiology: Beyond the Horizon.

Authors:  John W Jackson; Ian Schmid; Elizabeth A Stuart
Journal:  Curr Epidemiol Rep       Date:  2017-11-06

10.  Comparison of privacy-protecting analytic and data-sharing methods: A simulation study.

Authors:  Kazuki Yoshida; Susan Gruber; Bruce H Fireman; Sengwee Toh
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-07-18       Impact factor: 2.890

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.